Holoclara

Los Angeles, United States Founded: 2017 • Age: 9 yrs
Worm-derived therapies for allergic and autoimmune diseases are developed.
Annual revenue - Latest available
Total funding $16.0M 3 rounds
Employees - Tracked headcount
Investors 8 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Holoclara

Holoclara is a company based in Los Angeles (United States) founded in 2017 by Andrea Choe. Holoclara has raised $16 million across 3 funding rounds from investors including HHS, Bold Capital Partners and Horizons Ventures. Holoclara offers products and services including Worm-based Health Solutions and Health Research Offerings.

  • Headquarter Los Angeles, United States
  • Founders Andrea Choe
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Holoclara Inc
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $16 M (USD)

    in 3 rounds

  • Latest Funding Round
    $16 M (USD), Series A

    Jun 27, 2024

  • Investors
    HHS

    & 7 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Holoclara

Holoclara offers a comprehensive portfolio of products and services, including Worm-based Health Solutions and Health Research Offerings.

Product name locked
Category locked
Primary

Human health and aging are addressed through worm-based innovations that are developed by HOLOCLARA.

Product name locked
Category locked
Locked

Research on transforming human health and aging is conducted by HOLOCLARA using specified methodologies.

People of Holoclara

Headcount 1-10
Employee Profiles 6
Employee Profiles
People
Oliver Loson
VP Of Business Operations
People
Sarah Torres
Executive Assistant
People
Nicholas Everetts
Computational Biologist
People
Hung Nguyen
Vice President Of Preclinical Development

Unlock access to complete

Funding Insights of Holoclara

Holoclara has successfully raised a total of $16M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $16 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Holoclara

Holoclara has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Bold Capital Partners and Horizons Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage life sciences and tech focused VC firm investing primarily in the US
Locked Locked Locked
Horizons Ventures is focused on investing in deep science and technology.
Locked Locked Locked
Tech startups are accelerated and incubated by FreeFlow.
Locked Locked Locked
Premium access

Investor details for Holoclara

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Holoclara

Investments
Premium access

Investment portfolio details for Holoclara

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Holoclara

Premium access

Detailed financials for Holoclara

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Holoclara Comparisons

Holoclara Primary company
Description
Worm-derived therapies for allergic and autoimmune diseases ...
Location
Los Angeles, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Holoclara

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Holoclara

Premium access

Detailed competitors of Holoclara

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Holoclara

Premium access

Complete news archive for Holoclara

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Holoclara

Holoclara was founded in 2017.

Holoclara is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

Andrea Choe is the current CEO of Holoclara. They have also founded this company.

Holoclara is a funded company, having raised a total of $16M across 3 funding rounds to date.

Holoclara was established in 2017 in Los Angeles, United States, with Andrea Choe serving as founder and CEO. Operations center on biotechnology, where therapies sourced from worms are researched and developed to address allergic and autoimmune conditions. The focus remains on advancing treatments through this specialized approach, targeting disease management in the healthcare sector.

Holoclara offers Worm-based Health Solutions and Health Research Offerings.

Holoclara has 8 investors. Key investors include HHS, Bold Capital Partners, Horizons Ventures, FreeFlow Ventures, and Tarrasque.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available